Effect of Pitavastatin on Coronary Fibrous-cap Thickness - Assessment by Fourier-Domain Optical Coherence Tomography (ESCORT).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Pitavastatin (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- Acronyms ESCORT
- 28 Dec 2016 Planned End Date changed from 1 Sep 2012 to 1 Sep 2014.
- 28 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 21 Nov 2016 Planned number of patients changed from 60 to 70.